Harmonized labeling next step after ICH common technical document -- FDA's Woodcock.
This article was originally published in The Tan Sheet
Executive Summary
STANDARDIZED DRUG LABELING INDICATIONS IN U.S., EU AND JAPAN will be the next step toward a common International Conference on Harmonization review format after the common technical document is complete, Center for Drug Evaluation & Research Director Janet Woodcock, MD, told the recent Drug Information Association annual meeting in Boston. "There would have to be more harmonization of the indications" before regulating bodies in the U.S., the European Union and Japan could use a common review format, Woodcock said. "That is something that there is no formal process for."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: